Mindray (SZSE: 300760), a global leading developer and provider of medical devices and solutions, has announced the release of its latest general imaging diagnostic ultrasound system, Resona I9, to its suite of general imaging solutions. With innovations both inside and out, Resona I9 provides accurate and timely answers for clinicians, while delivering outstanding efficiency and a remarkable user experience.

Mindray (SZSE: 300760), a global leading developer and provider of medical devices and solutions, has announced the launch of its new General Imaging, Women’s Healthcare, and Cardiology ultrasound solutions on May 28, 2021. Underpinned by the theme “Innovation Defines”, each solution is specifically designed to increase the strength of diagnostic evidence available to doctors to ensure better patient care.

Mindray has launched its universally connected platform, M-Connect, which unlocks the potential of individual patient monitoring with an integrated IT solution. This innovative platform helps medical providers build a well-rounded healthcare ecosystem and greatly boosts efficiency.

Mindray (SZSE: 300760), a global leader in developing and providing medical devices, has released a new series of ceiling supply units which exceeds ISO 11197-2019 standards. The HyPort R80 is the newest generation of bedside device management systems with innovative designs among lighting system, workflow management and infection control. It helps caregivers provide safer and greater medical care by allowing for a more optimized, comfortable and efficient ICU environment.

Mindray (SZSE: 300760), a global leader in the development of innovative healthcare technology, has unveiled its new BeneFusion e Series, a revolutionary efficient infusion system for the healthcare industry. Available in three models, eSP, eVP and eDS, the BeneFusion e Series delivers efficiency in workflow, safety, application and informatics.

Mindray (SZSE: 300760), a global leader in the development of innovative healthcare technology, today launched its new VS 9 and VS 8 Vital Signs Monitors, which are now available in Europe, Australia and other selected regions. From inpatient admissions to spot checks, Mindray VS Series unlocks the full potential of routine observations, empowering clinicians to deliver patient-centric care.

This year’s China International Medical Equipment Fair (CMEF) was held in Shanghai on Oct 19-20. This time around, featured by the theme of Mindray in global actions to combat COVID-19, Mindray brought not only newly released flagship products but also hero stories from the forefront of combating COVID-19 to all visitors. During the MindShare session, the key innovative solutions were extensively unveiled and presented to the audience.

Mindray (SZSE: 300760), a global leader in the development of innovative healthcare technology, hosts a virtual launch event on October 15 to introduce its brand new A9 and A8 anesthesia systems, which is now available in Europe and other selected regions. This marks Mindray's entry as a key player in the high-end anesthesia machine market.